Coming together at the hinges: Therapeutic prospects of IgG3

por Chu, Thach H., Patz, Edward F., Ackerman, Margaret E.
Publicado 2021

Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis

por Bushey, Ryan T., Gottlin, Elizabeth B., Campa, Michael J., Patz, Edward F.
Publicado 2021

A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer

por Ashton, Jeffrey R., Gottlin, Elizabeth B., Patz, Edward F., West, Jennifer L., Badea, Cristian T.
Publicado 2018

Characterising phase variations in MALDI-TOF data and correcting them by peak alignment

por Lin, Simon M, Haney, Richard P, Campa, Michael J, Fitzgerald, Michael C, Patz, Edward F
Publicado 2007

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival

por Liu, Lihua, Liu, Hongliang, Luo, Sheng, Patz, Edward F., Glass, Carolyn, Su, Li, Lin, Lijuan, Christiani, David C., Wei, Qingyi
Publicado 2021

Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody

por Winkler, Mark T., Bushey, Ryan T., Gottlin, Elizabeth B., Campa, Michael J., Guadalupe, Eross S., Volkheimer, Alicia D., Weinberg, J. Brice, Patz, Edward F.
Publicado 2017

Novel genetic variants in genes of the Fc gamma receptor-mediated phagocytosis pathway predict non-small cell lung cancer survival

por Qian, Danwen, Liu, Hongliang, Zhao, Lingling, Wang, Xiaomeng, Luo, Sheng, Moorman, Patricia G., Patz, Edward F., Su, Li, Shen, Sipeng, Christiani, David C., Wei, Qingyi
Publicado 2020

Single nucleotide polymorphisms in FOXP1 and RORA of the lymphocyte activation-related pathway affect survival of lung cancer patients

por Du, Hailei, Mu, Rui, Liu, Lihua, Liu, Hongliang, Luo, Sheng, Patz, Edward F., Glass, Carolyn, Su, Li, Du, Mulong, Christiani, David C., Li, Hecheng, Wei, Qingyi
Publicado 2022

Genetic Variants of CLPP and M1AP Are Associated With Risk of Non-Small Cell Lung Cancer

por Li, Xianghan, Zou, Yiran, Li, Teng, Wong, Thomas K. F., Bushey, Ryan T., Campa, Michael J., Gottlin, Elizabeth B., Liu, Hongliang, Wei, Qingyi, Rodrigo, Allen, Patz, Edward F.
Publicado 2021

Tumour extracellular vesicle‐derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement‐dependent cytotoxicity of tumour cells

por Mao, Xiaowen, Zhou, Longyin, Tey, Sze Keong, Ma, Angel Po Yee, Yeung, Cherlie Lot Sum, Ng, Tung Him, Wong, Samuel Wan Ki, Liu, Bonnie Hei Man, Fung, Yi Man Eva, Patz, Edward F., Cao, Peihua, Gao, Yi, Yam, Judy Wai Ping
Publicado 2020

Upregulation of complement proteins in lung cancer cells mediates tumor progression

por Kleczko, Emily K., Poczobutt, Joanna M., Navarro, Andre C., Laskowski, Jennifer, Johnson, Amber M., Korpela, Sean P., Gurule, Natalia J., Heasley, Lynn E., Hopp, Katharina, Weiser-Evans, Mary C.M., Gottlin, Elizabeth B., Bushey, Ryan T., Campa, Michael J., Patz, Edward F., Thurman, Joshua M., Nemenoff, Raphael A.
Publicado 2023